Search Results - Sönnert-Husa, Sonja

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Dual targeting fixed duration frontline monoclonal antibody therapy for chronic lymphocytic leukemia: A phase 2 study

    Dual targeting fixed duration frontline monoclonal antibody therapy for chronic lymphocytic leukemia: A phase 2 study by Ma, Shuo, Rosen, Steven T., Winqvist, Maria, Frankfurt, Olga, Winter, Jane N., Gordon, Leo, Helenowski, Irene, Zhang, Hui, Kreutzer, Jennifer, Sönnert-Husa, Sonja, Österborg, Anders, Lundin, Jeanette

    Published in Leukemia research
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    A Phase 2 Study of Alemtuzumab-Ofatumumab (A+O) Combination in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) - an Update

    A Phase 2 Study of Alemtuzumab-Ofatumumab (A+O) Combination in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) - an Update by Lundin, Jeanette, Rosen, Steven T., Österborg, Anders, Frankfurt, Olga, Winter, Jane N., Rademaker, Alfred, Kreutzer, Jennifer, Bacon, Elizabeth, Sönnert-Husa, Sonja, Ma, Shuo

    Published in BLOOD
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: